4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-26-006707
Options or other derivatives
- Co-Chief Executive Officer acquired 16,688 shares (grant or award)
- Co-Chief Executive Officer returned 16,688 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Meckler Jeffrey A Co-Chief Executive Officer | 2026-02-11 | Returned to the company · Warrants (right to buy) | −3,033 | 0 | D | ||
| Meckler Jeffrey A Co-Chief Executive Officer | 2026-02-11 | Grant or award · Warrants (right to buy) | +3,033 | 3,033 | D | ||
| Meckler Jeffrey A Co-Chief Executive Officer | 2026-02-11 | Returned to the company · Warrants (right to buy) | −1,519 | 0 | D | ||
| Meckler Jeffrey A Co-Chief Executive Officer | 2026-02-11 | Grant or award · Warrants (right to buy) | +1,519 | 1,519 | D | ||
| Meckler Jeffrey A Co-Chief Executive Officer | 2026-02-11 | Returned to the company · Warrants (right to buy) | −12,136 | 0 | D | ||
| Meckler Jeffrey A Co-Chief Executive Officer | 2026-02-11 | Grant or award · Warrants (right to buy) | +12,136 | 12,136 | D | ||
Loading xslF345X05/ownership.xml…